Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-26 @ 2:16 AM
Study NCT ID:
NCT02658968
Status:
COMPLETED
Last Update Posted:
2024-01-16
First Post:
2015-12-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
Sponsor:
Nordic Nanovector
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EudraCT: 2015-001933-26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None